Клиническая эффективность коэнзима Q10 (Кудесан) в терапии ишемической болезни сердца у пациентов со стабильной стенокардией напряжения II–III функционального класса
Today secondary prevention of coronary heart disease (CHD) is one of the main strategic objectives of the Russian and world healthcare systems. Increasing importance is attached to the use of drugs, optimizing energy exchange of myocardial cells, such as coenzyme Q10 (Qudesan). This article presents...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SINAPS LLC
2012-08-01
|
Series: | Архивъ внутренней медицины |
Subjects: | |
Online Access: | https://www.medarhive.ru/jour/article/view/112 |
Summary: | Today secondary prevention of coronary heart disease (CHD) is one of the main strategic objectives of the Russian and world healthcare systems. Increasing importance is attached to the use of drugs, optimizing energy exchange of myocardial cells, such as coenzyme Q10 (Qudesan). This article presents the results of research of the effectiveness and tolerability of Qudesan in patients with CHD. |
---|---|
ISSN: | 2226-6704 2411-6564 |